| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.93▼ | 0.93▼ | 0.94▼ | 0.97▼ | 1.01▼ |
| MA10 | 0.93▼ | 0.94▼ | 0.95▼ | 0.99▼ | 1.06▼ |
| MA20 | 0.93▼ | 0.95▼ | 0.97▼ | 1.04▼ | 1.20▼ |
| MA50 | 0.95▼ | 0.98▼ | 0.99▼ | 1.08▼ | 1.17▼ |
| MA100 | 0.96▼ | 0.99▼ | 1.03▼ | 1.23▼ | 1.46▼ |
| MA200 | 0.99▼ | 1.04▼ | 1.05▼ | 1.16▼ | 2.01▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | -0.002▼ | -0.003▼ | -0.008▼ | -0.027▼ |
| RSI | 44.674▼ | 36.527▼ | 36.063▼ | 39.497▼ | 41.527▼ |
| STOCH | 29.948 | 13.993▼ | 31.747 | 24.689 | 15.118▼ |
| WILL %R | -76.947▼ | -86.828▼ | -90.281▼ | -97.489▼ | -99.257▼ |
| CCI | -26.384 | -115.430▼ | -157.469▼ | -135.439▼ | -101.472▼ |
|
Sunday, January 04, 2026 11:08 PM
InflaRx N.V. (NASDAQ: IFRX) is reviving hopes for vilobelimab after new analyses showed signs of efficacy in a Phase 3 trial it had previously halted, setting up FDA talks and a potential partner-led ...
|
|
Friday, January 02, 2026 03:38 AM
(RTTNews) - Despite the typical year-end slowdown, the week saw a steady stream of high-impact news, highlighted by global approvals, clinical trial readouts, new product launches, and strategic ...
|
|
Wednesday, December 10, 2025 11:30 PM
JENA, Germany, Dec. 11, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 28/01/26 | 0.975 | 0.975 | 0.9173 | 0.9249 | 518,714 |
| 27/01/26 | 0.96 | 1.00 | 0.9251 | 0.9667 | 700,986 |
| 26/01/26 | 1.00 | 1.01 | 0.931 | 0.931 | 662,490 |
| 23/01/26 | 1.01 | 1.03 | 0.9778 | 1.01 | 908,732 |
| 22/01/26 | 1.01 | 1.07 | 0.99 | 1.03 | 441,490 |
| 21/01/26 | 0.99 | 1.018 | 0.9581 | 1.00 | 320,923 |
| 20/01/26 | 1.00 | 1.01 | 0.9312 | 0.989 | 1,148,960 |
| 16/01/26 | 1.01 | 1.06 | 1.00 | 1.00 | 490,634 |
| 15/01/26 | 1.07 | 1.09 | 1.00 | 1.00 | 525,278 |
| 14/01/26 | 1.00 | 1.095 | 1.00 | 1.07 | 687,358 |
|
|
||||
|
|
||||
|
|